Enhance MD vs Next Vial
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes.
- semaglutide
- $249 per 4 weeks
- tirzepatide
- $329 per 4 weeks
Desk Score
People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
- semaglutide
- $250/mo
- tirzepatide
- Not confirmed for Next Vial.
Before enrolling
Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
Our review of Enhance MD gives it 79/100 (C+), while our review of Next Vial gives it 64/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
79/100
C+
64/100
C
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Enhance MD | Next Vial |
|---|---|---|
| Semaglutide | $249 per 4 weeksFull plan terms$249 every 4 weeks month-to-month (13 charges a year); $237/mo billed every 12 weeks, $224/mo billed every 24 weeks, $212/mo only on the 12-month prepay billed every 48 weeks | $250/moFull plan terms$250/mo (compounded) |
| Tirzepatide | $329 per 4 weeksFull plan terms$329 every 4 weeks month-to-month (13 charges a year); $313/mo billed every 12 weeks, $296/mo billed every 24 weeks, $280/mo only on the 12-month prepay billed every 48 weeks | Not confirmed for Next Vial. |
| Coverage | 40 states + DC (the FAQ names them; AL, AR, GA, HI, LA, MS, MO, ND, SC and TN are not served) | 49 states |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes. | People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner. |
| Desk Score | 79/100C+ | 64/100C |
The verdict
Desk pick — Enhance MDEnhance MD has the higher Desk Score, but Next Vial may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes.
People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Enhance MD
- CoreAge Rx vs Next Vial
- Enhance MD vs yourEra
- Next Vial vs Peak Wellness
- Enhance MD vs Peak Wellness
- Independent Wellness vs Next Vial
Or see the full comparison hub and the complete ranking.